HAEMONETICS CORP (HAE) › Net IncomeHAEMONETICS CORP (HAE) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: $59.30M2010: $58.37M2011: $79.98M2012: $66.89M2013: $38.80M2014: $35.15M2015: $16.90M2016: -$55.58M2017: -$26.27M2018: $45.57M2019: $55.02M2020: $76.53M2021: $79.47M2022: $43.38M2023: $115.40M2024: $117.56M2025: $167.68M2026: $97.31M$97.31M2009Net Income (USD)2026Fiscal YearNet IncomeChange YoY2026$97.31M-42.0%2025$167.68M+42.6%2024$117.56M+1.9%2023$115.40M+166.1%2022$43.38M-45.4%2021$79.47M+3.8%2020$76.53M+39.1%2019$55.02M+20.7%2018$45.57M+273.5%2017-$26.27M+52.7%2016-$55.58M-428.9%2015$16.90M-51.9%2014$35.15M-9.4%2013$38.80M-42.0%2012$66.89M-16.4%2011$79.98M+37.0%2010$58.37M-1.6%2009$59.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share